Synthesis 2008(19): 3065-3070  
DOI: 10.1055/s-2008-1067264
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Substituted Imidazo[1,2-h][1,7]naphthyridines as H+/K+-ATPase Inhibiting Drug Precursors via Directed ortho-Metalation of Imidazo[1,2-a]pyridines

Jörg Senn-Bilfinger*, Bernhard Kohl, Georg Rainer, Wilm Buhr, Hans Christof Holst, Peter Jan Zimmermann
ALTANA Pharma AG, now Nycomed GmbH, Byk-Gulden-Str.2, 78467 Konstanz, Germany
Fax: +49(7531)8492505; e-Mail: joerg.senn-bilfinger@nycomed.com;
Further Information

Publication History

Received 28 May 2008
Publication Date:
05 September 2008 (online)

Abstract

Selective directed ortho-metalation (DOM) of 2,3-di­methyl-8-(pivaloylamino)imidazo[1,2-a]pyridine in the 7-position was achieved with tert-butyllithium. Subsequent reaction of the lithiated derivative with tributylchlorostannane to the corresponding 7-trialkylstannyl analogue and palladium-catalyzed Stille acylation with 3-arylpropenoic acid chlorides in the presence of lithium chloride gave the corresponding 7-acylated imidazopyridines in good yields. Cyclization to the target imidazonaphthyridines, which are precursors in the synthesis of gastric H+/K+-ATPase inhibiting drugs, was achieved by treatment with strong acid. For scaled-up production of 2,3-dimethyl-9-phenyl-9,10-dihydroimidazo[1,2-h][1,7]naphthyridin-7(8H)-one, a tin-free process has been developed. Accordingly, the 7-lithiated 2,3-dimethyl-8-(pivaloyl­amino)imidazo[1,2-a]pyridine was reacted directly with cinnamaldehyde and the resultant alcohol oxidized with manganese dioxide to give the unsaturated 7-acylated imidazopyridine.

    References

  • For a review on DOM, see:
  • 1a Gschwend HW. Rodriguez HR. Org. React.  1979,  26:  1 
  • 1b Snieckus V. Chem. Rev.  1990,  90:  879 
  • 1c Queguiner G. Marsais F. Snieckus V. Epsztajn J. Adv. Heterocycl. Chem.  1991,  52:  187 
  • 2 Anctil EJ.-G. Snieckus V. Metal-Catalyzed Cross-Coupling Reactions   De Meijere A. Diederich F. Wiley-VCH; Weinheim: 2004.  p.761-813  
  • 3 Simon W.-A, Postius S, Riedel R, Senn-Bilfinger J, and Grundler G. inventors; WO  9842707. 
  • See, for example:
  • 4a Donnelly JA. Farrell DF. J. Org. Chem.  1990,  55:  1757 
  • 4b Xia Y. Yang Z.-Y. Xia P. Bastow KF. Tachibana Y. J. Med. Chem.  1998,  41:  1155 
  • 5 Blewitt HL. Special Topics in Heterocyclic Chemistry   Weissberger A. Tailor EC. Wiley; New York: 1977.  p.117 
  • 6a Tamura Y. Fujita M. Chen L.-C. Inoue M. Kita Y. J. Org. Chem.  1981,  46:  3564 
  • 6b Güngör T. Marsais F. Queguiner G. Synthesis  1982,  499 
  • 6c Turner JA. J. Org. Chem.  1983,  48:  3401 
  • For related reactions of heterocyclic stannanes with acyl chlorides, see, for example:
  • 7a Yamamoto Y. Yanagi A. Chem. Pharm. Bull.  1982,  30:  2003 
  • 7b Arukwe J. Benneche T. Undheim K. J. Chem. Soc., Perkin Trans. 1  1989,  255 
  • 7c Buron F. Plé N. Turck A. Queguiner G. J. Org. Chem.  2005,  70:  2616 
  • 8 For Stille cross-coupling reaction with imidazo[1,2-a]pyridines, see, for example: Hervet M. Théry I. Gueiffier A. Enguehard-Gueiffier C. Helv. Chim. Acta  2003,  86:  3461 
  • 9 For a review, see, for exampl: Farina V. Krishnamurthy V. Scott WJ. Org. React.  1997,  50:  1 
  • 10a Bumagin NA. Bumagina IG. Kashin AN. Beletskaya IP. J. Org. Chem. USSR (Engl. Transl.)  1982,  977 
  • 10b Labadie SS. Teng E. J. Org. Chem.  1994,  59:  4250 
  • 11a Scott WJ. Stille JK. J. Am. Chem. Soc.  1986,  108:  3033 
  • 11b Farina V. Krishnan B. Marshall DR. Roth GP. J. Org. Chem.  1993,  58:  5434 
  • 12a Senn-Bilfinger J, Postius S, Simon W.-A, Grundler G, Hanauer G, Huber R, Kromer W, and Sturm E. inventors; WO  0017200. 
  • 12b Simon W.-A. Herrmann M. Klein T. Shin jM. Huber R. Senn-Bilfinger J. Postius S. J. Pharmacol. Exp. Ther.  2007,  321 3:  866 
  • 12c Senn-Bilfinger J. Ferguson JR. Holmes MA. Lumbard KW. Huber R. Zech K. Hummel R.-P. Zimmermann PJ. Tetrahedron Lett.  2006,  47:  3321